Medical Affairs & Patient Safety Expertise
Safer trials. Stronger data.
Our medical experts participate in the planning and implementation of clinical programs to plan for and mitigate safety risks to patients while increasing data quality.
Our medical experts collaborate with clinical operations, biometrics teams, and medical writers to ensure patient safety throughout your clinical programs and marketing applications.
Benefit from the insight of MDs who stay directly connected to patients from trial start to finish. Veristat supports the medical safety of Phase I–IV clinical programs, offering medical and safety input into development plans, protocol design, feasibility, site selection, safety planning, and Key Opinion Leader (KOL) identification for your study or safety and data review committees.
That's why our medical experts don't work in isolation, they collaborate directly with clinical operations, biometrics, and medical writing teams throughout your program, so safety considerations inform decisions from protocol design forward, not just after something goes wrong.
Veristat Expertise in Medical Affairs
Veristat supports the medical safety of Phase I-IV clinical programs. We offer medical and safety input into the development plan, protocol design, feasibility considerations, site selection, safety planning, and Key Opinion Leader (KOL) identification for the study or safety/data review committees.
Veristat's Offerings
From safety planning to patient-facing support, here's how our medical affairs team protects your program at every phase.
Clinical Trial Safety
Planning and monitoring patient safety carefully and consistently at every stage throughout the trial and across study sites ensure that the proper safety reporting procedures are in place.
Learn more →Data Review & Safety Committees
Developing, recruiting and organizing Data Monitoring Committees to review clinical data throughout the trial to ensure patient safety.
Learn more →Medical Monitoring
Providing comprehensive and consistent oversight and support to ensure quality and compliance through the planning, duration and reporting phases of the clinical trial.
Learn more →MD Patient Support Services.
Supporting patient enrollment and increasing compliance while decreasing dropout rates and study delays.
Learn more →NEXT STEPS
What's Next in the Drug Development Process
Clinical Trial Safety.
Get the ongoing safety monitoring and reporting your program depends on.
Data Monitoring Committees.
Add independent safety oversight to protect patients and trial integrity.
Meet Our Experts
Gabriela Rosu M.D.
Senior Director, Global Medical Affairs
Gabriela Rosu, M.D., is the Senior Director, Global Medical Affairs at Veristat. In her role, Dr. Rosu is responsible for the leadership and strategic direction of the Global Medical Affairs department. Among her attributions are key client oversight and strategic project input, direct management of the medical affairs team, consulting activities, and medical oversight of ongoing clinical studies.
Keep patient safety at the center of every decision.
As clinical data evolves, so does the safety picture of your program. Veristat’s medical affairs experts bring medical judgment to that evidence, identifying what requires attention and guiding decisions throughout development—from protocol design and safety planning through study completion.
Frequently Asked Questions
Medical affairs experts provide medical and safety input into development plans, protocol design, feasibility, site selection, and Key Opinion Leader identification, working alongside clinical operations and biometrics teams from the earliest planning stages.
Veristat's MDs stay directly connected to patients from trial start to finish, collaborating across clinical operations, biometrics, and medical writing to ensure safety considerations are built into decisions throughout the program, not just addressed after issues arise.
Yes. Veristat develops, recruits, and organizes Data Monitoring Committees to review clinical data throughout the trial and help ensure patient safety.